JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.04B |
| 2 |
Truist Financial
TFC
|
+$964M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$909M |
| 4 |
Texas Instruments
TXN
|
+$800M |
| 5 |
Johnson & Johnson
JNJ
|
+$783M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$1.43B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.21B |
| 3 |
STI
SunTrust Banks, Inc.
STI
|
+$987M |
| 4 |
Microsoft
MSFT
|
+$980M |
| 5 |
CELG
Celgene Corp
CELG
|
+$929M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.95% |
| 2 | Financials | 11.95% |
| 3 | Healthcare | 9.46% |
| 4 | Consumer Discretionary | 8.62% |
| 5 | Industrials | 6.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ZNGA
1526
CALL
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $20.7M | ﹤0.01% |
3,389,900
-110,000
| -3% | -$680K |
|
1527
Timken Company
TKR
$8.91B
| $20.7M | ﹤0.01% |
366,895
-77,194
| -17% | -$3.9M |
|
1528
PagerDuty
PD
$915M
| $20.6M | ﹤0.01% |
880,174
+323,700
| +58% | +$7.96M |
|
1529
10x Genomics
TXG
$7.62B
| $20.5M | ﹤0.01% |
269,306
+54,155
| +25% | +$3.26M |
|
1530
Sabre
SABR
$803M
| $20.5M | ﹤0.01% |
914,211
+3,030
| +0.3% | +$67.2K |
|
1531
PUT
AbbVie
ABBV
$442B
| $20.5M | ﹤0.01% |
231,600
-180,900
| -44% | -$15M |
|
|
NPTN
1532
DELISTED
NEOPHOTONICS CORP
NPTN
| $20.5M | ﹤0.01% |
2,323,015
+1,614,282
| +228% | +$12.1M |
|
1533
Church & Dwight Co
CHD
$24.4B
| $20.4M | ﹤0.01% |
290,104
-10,487
| -3% | -$745K |
|
1534
Commault Systems
CVLT
$5.78B
| $20.3M | ﹤0.01% |
455,358
-34,377
| -7% | -$1.63M |
|
1535
Unisys
UIS
$205M
| $20.3M | ﹤0.01% |
1,710,315
+224,987
| +15% | +$2.26M |
|
1536
Progress Software
PRGS
$1.77B
| $20.3M | ﹤0.01% |
487,458
-67,420
| -12% | -$2.74M |
|
1537
PENN Entertainment
PENN
$2.57B
| $20.2M | ﹤0.01% |
792,049
+481,763
| +155% | +$10.7M |
|
1538
Louisiana-Pacific
LPX
$5.28B
| $20.2M | ﹤0.01% |
681,767
-770,177
| -53% | -$21.8M |
|
1539
Curtiss-Wright
CW
$26.1B
| $20.2M | ﹤0.01% |
143,402
+43,489
| +44% | +$5.89M |
|
1540
Vanguard Morningstar Mid-Cap Value ETF
VOE
$24.4B
| $20.2M | ﹤0.01% |
169,244
-18,361
| -10% | -$2.12M |
|
|
ORTX
1541
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $20.2M | ﹤0.01% |
+146,599
| New | +$17.8M |
|
|
LADR
1542
Ladder Capital
LADR
$1.26B
| $20.2M | ﹤0.01% |
1,117,081
+318,912
| +40% | +$5.5M |
|
|
BRSL
1543
CALL
Brightstar Lottery PLC
BRSL
$2.07B
| $20.1M | ﹤0.01% |
1,344,600
-117,300
| -8% | -$1.67M |
|
1544
Reliance Steel & Aluminium
RS
$21.6B
| $20.1M | ﹤0.01% |
167,860
-16,135
| -9% | -$1.83M |
|
1545
Liberty Global Class C
LBTYK
$3.4B
| $20.1M | ﹤0.01% |
922,108
-413,013
| -31% | -$9.29M |
|
1546
Helmerich & Payne
HP
$4.25B
| $20.1M | ﹤0.01% |
442,268
+99,309
| +29% | +$3.98M |
|
|
UCB
1547
United Community Banks
UCB
$4.36B
| $20.1M | ﹤0.01% |
650,422
+39,608
| +6% | +$1.2M |
|
1548
Minerals Technologies
MTX
$2.3B
| $20.1M | ﹤0.01% |
348,379
+76,100
| +28% | +$4.09M |
|
1549
Macerich
MAC
$6.96B
| $20.1M | ﹤0.01% |
744,994
+156,306
| +27% | +$4.29M |
|
1550
NGL Energy Partners
NGL
$2.13B
| $20M | ﹤0.01% |
1,767,078
+207,733
| +13% | +$2.31M |
|
Similar funds
JP Morgan Chase's Q4 2019 Portfolio in Review
As of Q4 2019, JP Morgan Chase held 6,136 positions worth $536B, up 6.8% from $502B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q4 2019 filing shows 374 new, 2,295 increased, 2,258 reduced and 490 closed positions. Its largest new stake was XP: 4,912,590 shares worth $189M. The largest sale was Pfizer, an estimated $1.43B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q4 2019 buy was XP: 4,912,590 shares worth $189M.
- JP Morgan Chase added most to iShares 20+ Year Treasury Bond ETF in Q4 2019, an estimated $1.04B increase.
- JP Morgan Chase's biggest Q4 2019 reduction was Pfizer, cutting an estimated $1.43B.
- JP Morgan Chase fully exited SunTrust Banks, Inc. in Q4 2019, selling an estimated $987M.
- JP Morgan Chase's ten largest holdings make up 17% of its $536B portfolio in Q4 2019.
- JP Morgan Chase opened 374 new positions and closed 490 in Q4 2019.
- JP Morgan Chase's portfolio value rose 6.8% quarter-over-quarter to $536B.
Based on JP Morgan Chase's 13F filing for Q4 2019, filed 11 Feb 2020.